|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
¶ – Release Delayed ·As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/26/15 Corindus Vascular Robotics, Inc. S-1/A¶ 95:7.5M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1.12M
(General Form)
95: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 37K
2: EX-1.1 Underwriting Agreement HTML 220K
3: EX-5.1 Opinion of Counsel re: Legality HTML 31K
4: EX-10.1 Material Contract HTML 74K
6: EX-10.16 Material Contract HTML 53K
7: EX-10.17 Material Contract HTML 32K
5: EX-10.2 Material Contract HTML 75K
8: EX-23.2 Consent of Experts or Counsel HTML 26K
64: R1 Document and Entity Information HTML 42K
51: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 144K
62: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 58K
(Parenthetical)
66: R4 Condensed Consolidated Statements of Operations HTML 80K
and Comprehensive Loss (Unaudited)
85: R5 Condensed Consolidated Statement of Stockholders' HTML 95K
Equity (Unaudited)
53: R6 Condensed Consolidated Statement of Stockholders' HTML 34K
Equity (Unaudited) (Parenthetical)
61: R7 Condensed Consolidated Statements of Cash Flows HTML 138K
(Unaudited)
46: R8 Condensed Consolidated Statements of Cash Flows HTML 30K
(Unaudited) (Parenthetical)
36: R9 Nature of Operations HTML 47K
87: R10 Significant Accounting Policies HTML 142K
68: R11 Reverse Acquisition HTML 47K
67: R12 Inventories HTML 39K
73: R13 Property and Equipment HTML 38K
74: R14 Notes Receivable HTML 32K
71: R15 Accrued Expenses HTML 35K
75: R16 Long-Term Debt HTML 45K
63: R17 Income Taxes HTML 49K
65: R18 Stockholders' Equity HTML 37K
70: R19 Stock-Based Compensation HTML 56K
94: R20 Warrants to Purchase Common Stock HTML 41K
81: R21 Commitments HTML 36K
57: R22 Net Loss per Share HTML 41K
69: R23 Restructuring Charge HTML 33K
59: R24 401(k) Plan HTML 31K
27: R25 Immaterial Correction of Errors HTML 32K
82: R26 Subsequent Events HTML 31K
90: R27 Related Party Transactions HTML 40K
41: R28 Significant Accounting Policies (Policies) HTML 179K
40: R29 Significant Accounting Policies (Tables) HTML 57K
44: R30 Reverse Acquisition (Tables) HTML 36K
45: R31 Inventories (Tables) HTML 38K
47: R32 Property and Equipment (Tables) HTML 37K
22: R33 Accrued Expenses (Tables) HTML 34K
79: R34 Long-Term Debt (Tables) HTML 37K
55: R35 Income Taxes (Tables) HTML 46K
58: R36 Stock-Based Compensation (Tables) HTML 56K
31: R37 Warrants to Purchase Common Stock (Tables) HTML 46K
93: R38 Commitments (Tables) HTML 32K
15: R39 Net Loss per Share (Tables) HTML 38K
48: R40 Nature of Operations - Additional Information HTML 82K
(Detail)
84: R41 Significant Accounting Policies - Additional HTML 198K
Information (Detail)
29: R42 Significant Accounting Policies - Schedule of HTML 39K
Assets and Liabilities Measured at Fair Value on a
Recurring Basis (Detail)
39: R43 Significant Accounting Policies - Roll-forward of HTML 36K
Warranty Liability (Detail)
43: R44 Significant Accounting Policies - Property and HTML 50K
Equipment, Estimated Useful Lives (Detail)
52: R45 Significant Accounting Policies - Assumptions Used HTML 43K
to Estimate Fair Value of Stock Options Granted
Using Black-Scholes-Merton Option Pricing Model
(Detail)
21: R46 Significant Accounting Policies - Schedule of HTML 35K
Concentration of Customers (Detail)
35: R47 Reverse Acquisition - Additional Information HTML 51K
(Detail)
17: R48 Reverse Acquisition - Schedule of Business HTML 44K
Acquisitions (Detail)
83: R49 Inventories - Schedule of Inventories Valued under HTML 40K
FIFO Method (Detail)
28: R50 Inventories - Additional Information (Detail) HTML 29K
80: R51 Property and Equipment - Additional Information HTML 31K
(Detail)
32: R52 Property and Equipment - Summary of Property and HTML 63K
Equipment, Net (Detail)
49: R53 Notes Receivable - Additional Information (Detail) HTML 43K
16: R54 Accrued Expenses - Schedule of Accrued Expenses HTML 53K
(Detail)
20: R55 Long-Term Debt - Additional Information (Detail) HTML 95K
42: R56 Long-Term Debt - Assumption for the Valuation of HTML 46K
Warrants Issued (Detail)
24: R57 Long-Term Debt - Schedule of Future Principal HTML 40K
Payments Under Borrowing Arrangement (Detail)
88: R58 Income Taxes - Reconciliation of Effective Income HTML 62K
Tax rate (Detail)
54: R59 Income Taxes - Schedule of Deferred Income Tax HTML 59K
Assets and Liabilities (Detail)
72: R60 Income Taxes - Additional Information (Detail) HTML 37K
34: R61 Stockholders' Equity - Additional Information HTML 32K
(Detail)
37: R62 Stock-Based Compensation - Additional Information HTML 61K
(Detail)
78: R63 Stock-Based Compensation - Summary of the Activity HTML 89K
Under the Company's Stock Option Plans (Detail)
76: R64 Stock-Based Compensation - Schedule of Stock-Based HTML 41K
Compensation Expense (Detail)
56: R65 Warrants to Purchase Common Stock - Additional HTML 39K
Information (Detail)
77: R66 Warrants to Purchase Common Stock - Rollforward of HTML 47K
Warrant Liability (Detail)
33: R67 Warrants to Purchase Common Stock - Schedule of HTML 46K
Assumptions in Revaluation of Outstanding Warrants
(Detail)
60: R68 Warrants to Purchase Common Stock - Schedule of HTML 45K
Warrants Outstanding (Detail)
89: R69 Commitments - Additional Information (Detail) HTML 43K
19: R70 Commitments - Schedule of Future Minimum Lease HTML 42K
Payments (Detail)
26: R71 Net Loss per Share - Schedule of Securities HTML 43K
Excluded from Computation of Net Loss per Share
(Detail)
50: R72 Restructuring Charge - Additional Information HTML 30K
(Detail)
23: R73 Immaterial Correction of Errors - Additional HTML 38K
Information (Detail)
92: R74 Stock-based Compensation - Summary of Assumptions HTML 41K
Used to Estimate the Fair Value of the Stock
Options Granted (Detail)
30: R75 Related Party Transactions - Additional HTML 66K
Information (Detail)
25: R76 Subsequent Events - Additional Information HTML 33K
(Detail)
91: XML IDEA XML File -- Filing Summary XML 142K
18: EXCEL IDEA Workbook of Financial Reports XLSX 180K
38: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 740K
9: EX-101.INS XBRL Instance -- cvrs-20150331 XML 1.17M
11: EX-101.CAL XBRL Calculations -- cvrs-20150331_cal XML 208K
12: EX-101.DEF XBRL Definitions -- cvrs-20150331_def XML 528K
13: EX-101.LAB XBRL Labels -- cvrs-20150331_lab XML 1.19M
14: EX-101.PRE XBRL Presentations -- cvrs-20150331_pre XML 873K
10: EX-101.SCH XBRL Schema -- cvrs-20150331 XSD 170K
86: ZIP XBRL Zipped Folder -- 0001193125-15-199337-xbrl Zip 167K
| EX-10.17 |
Exhibit 10.17
Directors’ Compensation Policy
Overview
The Board of Directors of Corindus Vascular Robotics, Inc. (the “Board”) has approved the following Director Compensation Policy (“Policy”) to provide an inducement to attract and retain the services of qualified persons to serve as directors.
Eligibility
This Policy shall apply to each director of the Board of Directors of Corindus Vascular Robotics, Inc. (the “Board”) who is not an employee of, or compensated consultant to, Corindus or any of its affiliates (a “non-employee director”). Employees of Corindus and their affiliates are not eligible to receive compensation under this Policy.
Director Compensation
Each non-employee director shall be compensated as follows:
| Outside Directors |
||||
| Annual Board Cash Retainer |
$ | 20,000 | ||
| Annual Equity Award (Stock Options) |
$ | 90,000 | ||
| Additional Board Chair Retainer |
$ | 8,000 | ||
| Additional Audit Committee Chair Retainer |
$ | 8,000 | ||
| Additional Compensation Committee Chair Retainer |
$ | 6,000 | ||
| Additional Nominating Committee Chair Retainer |
$ | 4,000 | ||
| Additional Audit Committee Member Retainer |
$ | 4,000 | ||
| Additional Compensation Committee Member Retainer |
$ | 3,000 | ||
| Additional Nominating Committee Member Retainer |
$ | 2,000 | ||
Equity Grants
Each Outside Director shall be granted under Corindus’ 2014 Stock Award Plan or any successor plan (the “Stock Award Plan”) stock options for shares of Corindus’ common stock each year at the annual meeting of the Board following Corindus’ annual meeting of stockholders beginning in calendar year 2016. The exercise price shall equal the closing price of a share of Corindus’ common stock on the grant date. The number of shares subject to the stock options shall be determined based on the Black-Scholes value of an option as of the grant date. The stock options shall vest 50% on the first anniversary of the grant date and 100% on the second anniversary of the grant date, subject to the outside director’s continued service on the Board. The grants shall vest in full immediately upon a Change in Control (as defined in the Stock Award Plan).
Payment Term for Cash Fees and Retainer
Cash payments to non-employee directors shall be paid quarterly in advance as of the first day of each fiscal quarter. Cash fees and retainers shall commence effective as of July 1, 2015, provided the Company has then completed an initial public offering. A non-employee director shall receive his or her cash compensation after first being elected or appointed to the Board on a pro-rated basis during the first fiscal quarter in which he or she was initially appointed or elected for the number of days during which he or she provides service.
Expense Reimbursement
Upon presentation of documentation of such expenses reasonably satisfactory to Corindus, each non-employee director shall be reimbursed for his or her reasonable out-of-pocket business expenses incurred in connection with attending meetings of the Board and its committees or in connection with other business related to the Board. Each non-employee director shall also be reimbursed for his or her reasonable out-of-pocket business expenses authorized by the Board or one of its committees that are incurred in connection with attendance at meetings with Corindus’ management. Each non-employee director shall abide by Corindus’ travel and other policies applicable to company personnel.
Policy Review / Amendments
The Compensation Committee or the Board shall review this Policy from time to time to assess whether any amendments in the type and amount of compensation provided herein should be adjusted in order to fulfill the objectives of this Policy. This Policy may only be amended by the Board.
Approved by the Corindus Vascular Robotics Board of Directors on May 18, 2015
2
| This ‘S-1/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 7/1/15 | ||||
| Filed on: | 5/26/15 | 424B3, 8-K, CORRESP, S-1/A | ||
| 5/18/15 | ||||
| List all Filings | ||||